Skip to content

Syphilis and HIV Point of Care Testing (POCT) in Saskatchewan

Syphilis and HIV Point of Care Testing (POCT) to Improve Access to Testing Among Inner City, Remote, Rural and Hard to Reach Populations in Saskatchewan

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05863117
Acronym
SHIVER
Enrollment
1650
Registered
2023-05-17
Start date
2023-02-01
Completion date
2024-07-31
Last updated
2023-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections, Syphilis

Keywords

point of care testing

Brief summary

The goal of this clinical trial is to learn about Syphilis and HIV point of care testing among inner city, remote, rural and hard to reach populations in Saskatchewan. The main question\[s\] it aims to answer are: 1. To evaluate the field diagnostic test performance (e.g. sensitivity, specificity, predictive values) of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for syphilis POCT, HIV POCT and dual syphilis and HIV POCT. 2. To evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically: 1. Time to diagnosis 2. Time to treatment 3. Number of contacts exposed to untreated infections 4. For HIV diagnoses, time to connection to clinical provider for ongoing management of HIV 3. To evaluate the acceptability and feasibility of POCT among different populations for syphilis and HIV among at risk and/or hard to reach populations, specifically: 1. Health care provider experiences of feasibility and acceptability of the POCT used in this pilot 2. Client acceptability and experiences with POCT in this pilot 3. Client preferences for test offered (syphilis only, HIV only, or dual test of HIV and syphilis 4. To evaluate the acceptability and feasibility of syphilis alone, HIV alone or combined syphilis/HIV POCT among at-risk and/or hard to reach populations. Participants will be assessed for risk factors that may increase risk of infectious disease such as substance use and sexual habits. They will then be offered a choice of 1 of 3 POCT(Syphilis alone, HIV alone or a dual HIV/Syphilis test). Serology will be obtained for sexually transmitted and blood born infections (STBBI's) and then the point of care test (POCT) will be completed. Following the testing the participant will complete a short survey on their experience.

Interventions

DIAGNOSTIC_TESTReveal Rapid TP (from MedMira)

Point of care tests for HIV and Syphilis

Sponsors

CIHR Canadian HIV Trials Network
CollaboratorNETWORK
University of Saskatchewan
CollaboratorOTHER
Saskatchewan Health Authority - Regina Area
CollaboratorOTHER
Wellness Wheel Medical Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 1650 consecutive individuals * \> 16 years accessing STBBI testing at specific locations and able to provide informed consent. PLWH and persons who are syphilis positive may also eligible to participate.

Exclusion criteria

° Less than 16 years, unable to provide signed informed consent (e.g., intoxicated)

Design outcomes

Primary

MeasureTime frameDescription
Syphilis-Comparison between point of care testing and serology testing for Syphilis and HIV12-18 monthsTo evaluate the field diagnostic test performance of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for syphilis POCT.
HIV- Comparison between point of care testing and serology testing for Syphilis and HIV12-18 monthsHIV- To evaluate the field diagnostic test performance of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for HIV POCT.
Syphilis/HIV- Comparison between point of care testing and serology testing for Syphilis and HIV12-18 monthsDual HIV/Syphilis-To evaluate the field diagnostic test performance of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for dual syphilis and HIV POCT.

Secondary

MeasureTime frameDescription
Dual HIV/Syphilis-Comparison of acceptability and feasibility by using a patient experience survey of syphilis alone, HIV alone and dual HIV/Syphilis point of care testing among different populations.12-18 monthsTo evaluate the acceptability and feasibility of combined syphilis/HIV POCT among at-risk and/or hard to reach populations
Syphilis-Comparison of acceptability and feasibility by using a patient experience survey of syphilis alone, HIV alone and dual HIV/Syphilis point of care testing among different populations.12-18 monthsTo evaluate the acceptability and feasibility of syphilis alone, among at-risk and/or hard to reach populations
Time to diagnosis-Clinical utility of POCT for management and follow up of Syphilis and HIV12-18 monthsTo evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically: Time to diagnosis
Number of contacts-Clinical utility of POCT for management and follow up of Syphilis and HIV12-18 monthsTo evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically: Number of contacts exposed to untreated infections
Time to connection-Clinical utility of POCT for management and follow up of Syphilis and HIV12-18 monthsTo evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically: For HIV diagnoses, time to connection to clinical provider for ongoing management of HIV.
Time to treatment-Clinical utility of POCT for management and follow up of Syphilis and HIV12-18 monthsTo evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically:Time to treatment
Evaluate the acceptability and feasibility of POCT for syphilis and HIV12-18 monthsTo evaluate the acceptability and feasibility by using a patient experience survey of POCT among different populations for syphilis and HIV among at risk and/or hard to reach populations, specifically: Health care provider experiences of feasibility and acceptability of the POCT used in this pilot b) Client acceptability and experiences with POCT in this pilot c) Client preferences for test offered (syphilis only, HIV only, or dual test of HIV and syphilis
HIV-Comparison of acceptability and feasibility by using a patient experience survey of syphilis alone, HIV alone and dual HIV/Syphilis point of care testing among different populations.12-18 monthsTo evaluate the acceptability and feasibility of HIV alone among at-risk and/or hard to reach populations

Countries

Canada

Contacts

Primary ContactNikki Williamson, RN
nikki.williamson@wellnesswheelclinic.ca1-306-526-7350
Backup ContactSusanne Nicolay, RN
susanne.nicolay@wellnesswheelclinic.ca1-306-520-2846

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026